Highlighting the Top 20 scientists in two categories: cannabis analysis and cannabis research.
How are Canadians using medical cannabis?
Freeing the roads of THC-intoxicated drivers, one breathalyzer test at a time
The message is clear: we need more evidence. But are randomized, controlled trials the answer?
Does CBD really counteract the neuropsychiatric risks of THC?
Could synthetic biology facilitate a microbial revolution... and do away with grow rooms for good?
Heavy metal contaminants pose a risk to health – the cannabis industry must react accordingly.
Sitting Down With... Mike Barnes, Chief Medical Officer, Lyphe Group, London, UK and Chairman, Maple Tree Consultancy, Chester, UK.
A dose-escalation study aims to quantify the value of CBD in children with epileptic encephalopathy.
Restrictive legislation won’t prevent efforts to progress cannabis research
Regulating cannabis vape flavors may have negative consequences for wider cannabis research… Unless industry acts quickly
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.